Document is current
Any future updates will be listed below
-
Authors
Kikuchi, Taku https://orcid.org/0000-0002-3210-7756
Sugita, Shotaro
Kondo, Ukyo
Watanabe, Miyu
Matsumoto, Chiaki
Nomura-Yogo, Moe
Kunisada, Kodai
Sato, Kota
Takei, Tomomi
Ogura, Mizuki
Abe, Yu
Hosoya, Osamu
Ishida, Tadao
Tsukada, Nobuhiro
- License Information
-
More Information
Article History
Received: 27 September 2025
Revised: 27 November 2025
Accepted: 30 November 2025
First Online: 3 December 2025
Declarations
:
: TK received personal fees from Janssen Pharmaceuticals (Titusville, NJ, USA), Takeda (Osaka, Japan), Bristol-Myers Squibb (New York, NY, USA), Pfizer (New York, NY, USA), and Sanofi (Paris, France). NT received personal fees from Janssen and Sanofi. TI received honoraria from Ono Pharmaceutical Co., Ltd. (Osaka, Japan), Takeda, Celgene/Bristol-Myers Squibb, and Janssen. The other authors declare that they have no conflicts of interest.
: This study was approved by the Institutional Review Board of the Japanese Red Cross Medical Center (JRCMC; Tokyo, Japan) and was conducted under an abbreviated informed consent procedure and an opt-out consent principle. No participants were excluded from the study. The study was conducted in accordance with the principles of the Declaration of Helsinki.
